Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.800
-0.070 (-3.74%)
Sep 10, 2025, 3:17 PM - Market open
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $22.97 million as of September 10, 2025.
Market Cap
22.97M
Enterprise Value
25.06M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since August 15, 2025, Propanc Biopharma's market cap has decreased from $36.20M to $22.97M, a decrease of -36.54%. That is a compound annual growth rate of -99.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 24.60M | -9.23% |
| Sep 5, 2025 | 27.10M | 8.40% |
| Sep 4, 2025 | 25.00M | -21.14% |
| Sep 3, 2025 | 31.70M | -7.85% |
| Sep 2, 2025 | 34.40M | -9.71% |
| Aug 29, 2025 | 38.10M | -3.05% |
| Aug 28, 2025 | 39.30M | 5.93% |
| Aug 27, 2025 | 37.10M | -2.88% |
| Aug 26, 2025 | 38.20M | -10.12% |
| Aug 25, 2025 | 42.50M | - |
| Aug 22, 2025 | 42.50M | -16.99% |
| Aug 21, 2025 | 51.20M | -7.75% |
| Aug 20, 2025 | 55.50M | 19.87% |
| Aug 19, 2025 | 46.30M | -37.26% |
| Aug 18, 2025 | 73.80M | 103.87% |
| Aug 15, 2025 | 36.20M | - |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |